leisure time -WSS

leisure time

author：hotspot 2025-09-29 12:30:00 - browse：96995

Cambridge: Biogen — Ruby Wallau for STAT

Biogen is joining the industry’s fervor over immune and inflammatory disease drug development with a new acquisition.

The Cambridge, Mass., drugmaker announced Wednesday that it will acquire Human Immunology Biosciences, or HI-Bio, for $1.15 billion and up to $650 million in additional payments if certain milestones are met.

HI-Bio, which is based in San Francisco, is developing therapies for immune-mediated diseases like primary membranous nephropathy and IgA nephropathy, both of which impact kidney function. The startup’s lead drug, felzartamab, is a monoclonal antibody that selectively depletes CD38+ and natural killer cells in the hopes of alleviating the disease’s effects. It has already completed Phase 2 studies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Shingles, which affected Dianne Feinstein, is on the rise

WSS

Sweden knocks USA out of World Cup in penalty kicks

After a drawn out lobbying fight, ARPA

Russia promises retaliation after Ukrainian drones hit a Russian tanker in 2nd sea attack in a day

Address the ethical violations that led to 'Three Identical Strangers'

Inequities make cancer less preventable for women: report

WHO recommends dropping component of many flu vaccines

entertainment

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Election results set back Medicaid expansion plans

DIEP, the 'gold standard' of breast reconstruction, is under threat

With heat waves through August, officials warn of health risks

Guidelines to prevent youth baseball injuries need more muscle

Election results set back Medicaid expansion plans

In age of alternative facts, a scholarly course on calling out crap

Menendez indictment could see pharma lose a key ally

Guidelines to prevent youth baseball injuries need more muscle

Sage considers ways to reduce costs following FDA rejection

focus

Doctors are clamoring for more clarity on Paxlovid prescribing

Cigna to pay $172 million to settle Medicare Advantage fraud probe

Election results set back Medicaid expansion plans

How one patient went off dialysis — and others can too

Did you have Obamacare on your GOP debate bingo card?

Inequities make cancer less preventable for women: report

knowledge

leisure time

explore

Wikipedia